UroGen Pharma (URGN) Stock Chart & Stock Price History → FW: 234x Gain (From Weiss Ratings) (Ad) Free URGN Stock Alerts $14.30 +0.04 (+0.28%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability UroGen Pharma Stock Price Performance5 Day Performance+1.85%1 Month Performance+4.84%3 Month Performance-13.18%6 Month Performance+23.60%Year-To-Date Performance-4.67%1 Year Performance+14.31% Receive URGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for UroGen Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. URGN Stock Chart for Saturday, May, 4, 2024 URGN Chart by TradingView UroGen Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$14.26$14.30+0.28%$14.70$14.14164,409 shs$335.34 million05/02/2024$14.40$14.26-0.97%$14.60$14.18157,599 shs$334.40 million05/01/2024$13.82$14.40+4.20%$14.70$13.89179,883 shs$337.68 million04/30/2024$14.04$13.82-1.57%$14.15$13.78217,754 shs$324.08 million04/29/2024$14.15$14.04-0.78%$14.68$13.92198,391 shs$329.29 million04/26/2024$13.82$14.15+2.39%$14.32$13.69135,569 shs$331.82 million Get the Latest News and Ratings for URGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for UroGen Pharma and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$14.21$13.82-2.74%$14.50$13.77185,411 shs$324.08 million04/24/2024$14.53$14.21-2.20%$14.76$14.1997,025 shs$333.22 million04/23/2024$14.37$14.53+1.11%$14.85$14.11216,766 shs$340.73 million04/22/2024$13.73$14.37+4.66%$14.52$13.58278,571 shs$336.98 million04/19/2024$14.26$13.73-3.72%$14.28$13.17389,406 shs$321.97 million04/18/2024$14.24$14.26+0.14%$14.54$13.96315,324 shs$334.40 million04/17/2024$14.49$14.24-1.73%$14.66$14.02187,493 shs$333.93 million04/16/2024$15.10$14.49-4.04%$15.05$14.16409,956 shs$339.79 million04/15/2024$15.10$15.10$15.43$14.21661,672 shs$354.16 million04/12/2024$13.25$15.10+13.96%$15.21$13.001.23 million shs$354.10 million04/11/2024$12.95$13.25+2.32%$13.25$12.37258,705 shs$310.77 million04/10/2024$13.37$12.95-3.14%$13.20$12.58319,274 shs$303.73 million04/09/2024$13.21$13.37+1.21%$13.91$13.21204,206 shs$313.53 million04/08/2024$13.60$13.21-2.87%$13.64$13.18125,207 shs$309.77 million04/05/2024$13.64$13.60-0.29%$13.98$13.21128,770 shs$318.92 million04/04/2024$13.66$13.64-0.15%$14.30$13.50220,283 shs$319.86 million04/03/2024$14.09$13.66-3.05%$14.26$13.47176,359 shs$320.33 million04/02/2024$14.20$14.09-0.77%$14.52$13.00194,210 shs$330.41 million04/01/2024$15.00$14.20-5.33%$14.75$14.16195,465 shs$332.99 million03/29/2024$15.00$15.00$15.25$14.56175,784 shs$351.75 million03/28/2024$14.96$15.00+0.27%$15.25$14.56175,784 shs$351.75 million03/27/2024$15.17$14.96-1.38%$15.67$14.46248,981 shs$350.81 million03/26/2024$16.66$15.17-8.94%$16.85$14.99390,121 shs$355.74 million03/25/2024$15.76$16.66+5.71%$18.23$16.00895,258 shs$369.64 million03/22/2024$14.94$15.76+5.49%$16.17$14.732.25 million shs$369.57 million03/21/2024$14.96$14.94-0.13%$15.16$14.57396,998 shs$350.34 million03/20/2024$15.02$14.96-0.40%$15.18$14.31205,509 shs$350.81 million03/19/2024$14.50$15.02+3.59%$15.23$14.18274,489 shs$352.22 million03/18/2024$14.46$14.50+0.28%$14.58$13.83294,594 shs$340.03 million03/15/2024$14.33$14.46+0.91%$14.84$13.86407,066 shs$339.09 million03/14/2024$17.47$14.33-17.97%$16.89$14.14620,551 shs$336.04 million03/13/2024$17.62$17.47-0.85%$17.83$16.88124,579 shs$409.67 million03/12/2024$17.10$17.62+3.04%$17.75$16.84237,594 shs$413.19 million03/11/2024$17.99$17.10-4.95%$18.29$16.96258,949 shs$401.06 millionThe Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide.03/08/2024$18.03$17.99-0.22%$18.62$17.70197,776 shs$421.87 million03/07/2024$18.05$18.03-0.11%$18.59$17.80197,277 shs$422.80 million03/06/2024$18.01$18.05+0.22%$18.46$17.88446,057 shs$423.27 million03/05/2024$18.42$18.01-2.23%$18.48$17.96307,816 shs$422.34 million03/04/2024$17.77$18.42+3.66%$18.63$17.47151,565 shs$431.95 million03/01/2024$18.33$17.77-3.06%$18.19$16.30370,630 shs$416.71 million02/29/2024$18.17$18.33+0.88%$18.65$17.90327,033 shs$429.84 million02/28/2024$18.59$18.17-2.26%$18.55$17.44157,148 shs$426.09 million02/27/2024$17.96$18.59+3.51%$18.72$18.0092,798 shs$435.94 million02/26/2024$17.09$17.96+5.09%$17.96$17.05108,024 shs$421.23 million02/23/2024$17.79$17.09-3.93%$17.79$16.94121,912 shs$400.76 million02/22/2024$17.69$17.79+0.57%$18.04$17.3498,851 shs$417.18 million02/21/2024$19.24$17.69-8.06%$19.21$17.54215,898 shs$414.83 million02/20/2024$19.33$19.24-0.47%$19.74$18.95312,725 shs$451.18 million02/19/2024$19.33$19.33$19.87$18.15450,800 shs$453.29 million02/16/2024$18.80$19.33+2.82%$19.87$18.15424,058 shs$453.29 million02/15/2024$19.22$18.80-2.19%$19.66$18.681.68 million shs$440.86 million02/14/2024$18.75$19.22+2.51%$19.33$18.87250,342 shs$450.71 million02/13/2024$19.30$18.75-2.85%$19.31$18.44267,363 shs$439.69 million02/12/2024$18.98$19.30+1.69%$19.59$18.97325,082 shs$452.59 million02/09/2024$18.50$18.98+2.59%$19.27$18.53316,435 shs$445.08 million02/08/2024$16.02$18.50+15.48%$18.63$16.10466,160 shs$433.83 million02/07/2024$16.01$16.02+0.06%$16.09$15.63823,733 shs$375.67 million02/06/2024$15.99$16.01+0.13%$16.31$15.84192,976 shs$375.44 million02/05/2024$16.47$15.99-2.91%$16.38$15.82369,955 shs$374.97 million Related Companies: Terns Pharmaceuticals Stock Chart Rani Therapeutics Stock Chart Precigen Stock Chart Nkarta Stock Chart Atai Life Sciences Stock Chart Neoleukin Therapeutics Stock Chart Silverback Therapeutics Stock Chart Atea Pharmaceuticals Stock Chart Organogenesis Stock Chart FibroBiologics Stock Chart Receive URGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for UroGen Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:URGN) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UroGen Pharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.